How exercise and diet affect muscle loss in older adults with HIV
The Influence of Habitual Physical Activity and Diet in the Development of Sarcopenia Among Older Adults With HIV
This study is looking at how staying active and eating well can help prevent muscle loss in older adults living with HIV, and it aims to find ways to keep your muscles strong as you age.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10821495 on NIH RePORTER |
What this research studies
This research investigates how regular physical activity and dietary habits influence the development of sarcopenia, a condition characterized by muscle loss, in older adults living with HIV. The study aims to identify the relationship between lifestyle factors and the onset of sarcopenia, which is particularly prevalent in this population. By examining these factors, the research seeks to develop effective interventions that can help prevent or mitigate muscle loss among older adults with HIV. Participants may be asked to engage in specific exercise regimens and dietary modifications to assess their impact on muscle health.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 50 and above who are living with HIV and may be experiencing or at risk for sarcopenia.
Not a fit: Patients who are not living with HIV or those who are younger than 50 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing muscle loss in older adults with HIV, enhancing their quality of life and independence.
How similar studies have performed: Previous research has shown that lifestyle interventions, including exercise and dietary changes, can effectively reduce the risk of sarcopenia in older populations, suggesting a promising avenue for this study.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Oliveira, Vitor — University of Washington
- Study coordinator: Oliveira, Vitor
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.